Adams J - Search Results

1

Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor.

Merluzzi VJ, Hargrave KD, Labadia M, Grozinger K, Skoog M, Wu JC, Shih CK, Eckner K, Hattox S, Adams J, et al. Merluzzi VJ, et al. Among authors: adams j. Science. 1990 Dec 7;250(4986):1411-3. doi: 10.1126/science.1701568. Science. 1990. PMID: 1701568

2

Crystal structure of nevirapine, a non-nucleoside inhibitor of HIV-1 reverse transcriptase, and computational alignment with a structurally diverse inhibitor.

Mui PW, Jacober SP, Hargrave KD, Adams J. Mui PW, et al. Among authors: adams j. J Med Chem. 1992 Jan;35(1):201-2. doi: 10.1021/jm00079a029. J Med Chem. 1992. PMID: 1370694 No abstract available.

3

Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. 5. 4-Substituted and 2,4-disubstituted analogs of nevirapine.

Kelly TA, Proudfoot JR, McNeil DW, Patel UR, David E, Hargrave KD, Grob PM, Cardozo M, Agarwal A, Adams J. Kelly TA, et al. Among authors: adams j. J Med Chem. 1995 Nov 24;38(24):4839-47. doi: 10.1021/jm00024a011. J Med Chem. 1995. PMID: 7490733

4

Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 7. 8-Arylethyldipyridodiazepinones as potent broad-spectrum inhibitors of wild-type and mutant enzymes.

Klunder JM, Hoermann M, Cywin CL, David E, Brickwood JR, Schwartz R, Barringer KJ, Pauletti D, Shih CK, Erickson DA, Sorge CL, Joseph DP, Hattox SE, Adams J, Grob PM. Klunder JM, et al. Among authors: adams j. J Med Chem. 1998 Jul 30;41(16):2960-71. doi: 10.1021/jm9707028. J Med Chem. 1998. PMID: 9685235

5

A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site.

Wu JC, Warren TC, Adams J, Proudfoot J, Skiles J, Raghavan P, Perry C, Potocki I, Farina PR, Grob PM. Wu JC, et al. Among authors: adams j. Biochemistry. 1991 Feb 26;30(8):2022-6. doi: 10.1021/bi00222a003. Biochemistry. 1991. PMID: 1705436

6

Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587.

Koup RA, Merluzzi VJ, Hargrave KD, Adams J, Grozinger K, Eckner RJ, Sullivan JL. Koup RA, et al. Among authors: adams j. J Infect Dis. 1991 May;163(5):966-70. doi: 10.1093/infdis/163.5.966. J Infect Dis. 1991. PMID: 1708400

7

Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase.

Cohen KA, Hopkins J, Ingraham RH, Pargellis C, Wu JC, Palladino DE, Kinkade P, Warren TC, Rogers S, Adams J, et al. Cohen KA, et al. Among authors: adams j. J Biol Chem. 1991 Aug 5;266(22):14670-4. J Biol Chem. 1991. PMID: 1713587 Free article.

8

Prophylaxis against HIV-1 infection in chimpanzees by nevirapine, a nonnucleoside inhibitor of reverse transcriptase.

Grob PM, Cao Y, Muchmore E, Ho DD, Norris S, Pav JW, Shih CK, Adams J. Grob PM, et al. Among authors: adams j. Nat Med. 1997 Jun;3(6):665-70. doi: 10.1038/nm0697-665. Nat Med. 1997. PMID: 9176494

9

BIRM 270: a novel inhibitor of arachidonate release that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils.

Farina PR, Graham AG, Hoffman AF, Watrous JM, Borgeat P, Nadeau M, Hansen G, Dinallo RM, Adams J, Miao CK, et al. Farina PR, et al. Among authors: adams j. J Pharmacol Exp Ther. 1994 Dec;271(3):1418-26. J Pharmacol Exp Ther. 1994. PMID: 7996454

10

Inhibition of herpes simplex virus type 1 ribonucleotide reductase by substituted tetrapeptide derivatives.

Moss N, Déziel R, Adams J, Aubry N, Bailey M, Baillet M, Beaulieu P, DiMaio J, Duceppe JS, Ferland JM, et al. Moss N, et al. Among authors: adams j. J Med Chem. 1993 Oct 1;36(20):3005-9. doi: 10.1021/jm00072a021. J Med Chem. 1993. PMID: 8411018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,807 results

Search Page